The aim of the present study was to investigate the protective effect of the peroxynitrite decomposition catalyst 5,10,15,20-tetrakis(2,4,6-trimethyl-3,5-disulfonatophenyl)-porphyrinato iron (III) (FeTMPS) in a model of splanchnic artery occlusion shock (SAO). SAO shock was induced in rats by clamping both the superior mesenteric artery and the celiac trunk for 45 min, followed by release of the clamp (reperfusion). At 60 min after reperfusion, animals were killed for histological examination and biochemical studies. There was a marked increase in the oxidation of dihydrorhodamine 123 to rhodamine (a marker of peroxynitrite-induced oxidative processes) in the plasma of the SAOshocked rats after reperfusion, but not during ischemia alone. Immunohistochemical examination demonstrated a marked increase in the immunoreactivity to nitrotyrosine, an index of nitrogen species such as peroxynitrite, in the necrotic ileum in shocked rats. SAO-shocked rats developed a significant increase of tissue myeloperoxidase and malonaldehyde activity, and marked histological injury to the distal ileum. SAO shock was also associated with a significant mortality (0% survival at 2 h after reperfusion). Reperfused ileum tissue sections from SAO-shocked rats showed positive staining for Pselectin localized mainly in the vascular endothelial cells. Ileum tissue sections obtained from SAOshocked rats and stained with antibody to ICAM-1 showed a diffuse staining. Administration of FeT-MPS significantly reduced ischemia/reperfusion injury in the bowel, and reduced lipid and the production of peroxynitrite during reperfusion. Treatment with PN catalyst also markedly reduced the intensity and degree of P-selectin and ICAM-1 staining in tissue sections from SAO-shocked rats and improved survival. Our results clearly demonstrate that peroxynitrite decomposition catalysts exert a protective effect in SAO and that this effect may be due to inhibition of the expression of adhesion molecules and the tissue damage associated with peroxynitriterelated pathways.-Cuzzocrea, S., Misko, T. P., Costantino, C., Mazzon, E., Micali, A., Caputi, A. P., Macarthur, H., Salvemini, D. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion.
Occlusion of the splanchnic circulation followed by reperfusion (SAO) results in a severe form of circulatory shock characterized by severe hypotension, hemoconcentration, intestinal injury, and a high mortality rate (1, 2) . An important component of SAO shock is endothelial dysfunction (1, (3) (4) (5) . In fact, a reduction in the ecNOS activity in reperfused intestine has been demonstrated by direct enzyme measurements by Kanwar and co-workers (6) .
The development of endothelial dysfunction was originally attributed to oxygen-derived free radicals released from both the reperfused endothelium (1, 7) and activated adherent polymorphonuclear leukocytes (PMNs) (8 -11) . The endothelial dysfunction (i.e., a deficit of endothelial nitric oxide production) predisposes to vasospasm, platelet deposition, and increased neutrophil adherence, which exacerbate the shock state.
Ischemia-reperfusion is a stimulus for leukocyteendothelial interaction (12) . Loss of endothelialderived nitric oxide (NO) is known to be one of the earliest manifestations of ischemia-reperfusion in-jury (13) , and this reduced NO is no longer able to significantly reduce leukocyte-endothelial interaction (14) . Leukocyte-endothelial interaction involves a complex system of adhesion molecules including the selectins, ␤ 2 integrins, and the immunoglobulin superfamily (15) (16) (17) . Leukocyte interaction with the endothelium begins with leukocyte rolling, followed by adherence and transendothelial migration. P-selectin, a member of the selectin family of adhesion molecules, is believed to play a major role in the initial phase of leukocyte emigration, which is characterized by the rolling of leukocytes along the vascular endothelial surface. PMN rolling serves to tether the unstimulated neutrophil to activated endothelium, thus bringing the neutrophil in closer contact with adhesion-promoting substances such as platelet-activating factor (18) . Although Pselectin is necessary for early neutrophil contact with the endothelium, P-selectin-mediated leukocyte-endothelial interaction is not sufficient to allow neutrophil emigration from the vessel. A firmer adherence of the neutrophil to the endothelial surface is required for transendothelial migration (19) . This firm adherence involves the interaction of ␤ 2 integrins (i.e., CD11/CD18) on the PMN surface and intercellular adhesion molecule 1 (ICAM-1) on the endothelial cell surface (19, 20) . ICAM-1 has a molecular mass of 95 kDa (21) . The binding molecules for ICAM-1 in neutrophils and monocytes are the integrin ligands LFA-1 and Mac-1 (21, 22) . De novo expression of ICAM-1 has been described in different cell types in inflammatory lesion, during rejection, and on melanoma cells (23, 24) . Experimental studies have also showed that antibodies against ICAM-1 inhibit leukocyte adhesion to endothelial cells, granulocyte migration through endothelium, and mixed lymphocyte reactions in vitro (25, 26) . In addition, in vivo administration of antibodies raised against ICAM-1 reduces neutrophil infiltration into the inflamed lungs in the rabbit and protects the development of SAO-induced injury.
Recent evidence suggests that peroxynitrite (ONOO Ϫ ), a toxic oxidant formed from the reaction of NO and superoxide, is present in the reperfused heart (27, 28) , liver (29) , kidney (30) , intestine (31), brain (32) , and lung (33) . The biological activity and decomposition of peroxynitrite is dependent on the cellular or chemical environment (presence of proteins, thiols, glucose, the ratio of NO and superoxide, carbon dioxide levels, and other factors), and these factors influence its toxic potential (34) .
The cytotoxic effect of peroxynitrite toward the vascular endothelium has been directly demonstrated in reperfused hearts (27, 28) and cultured human umbilical vein endothelial cells (35) . Therefore, in the presence of superoxide generators, agonist-induced release of NO from ecNOS exerts autocrine cytotoxic effects via the generation of peroxynitrite, which can be prevented by inhibition of endothelial NOS in vitro (36) . Last, data from in vivo/ex vivo experiments suggest that under certain conditions, e.g., during hypercholesterolemia and atherosclerosis (37) and during endotoxic shock (38) , endothelium-derived NO can combine with superoxide, and the resulting formation of peroxynitrite causes an impairment of the endothelial function. To date, the data generated to support the role of ONOO in vivo are indirect and have relied mainly on pharmacological (presumed inhibition of ONOO through reduction of NO by NOS inhibitors) and biochemical (measurement of rhodamine oxidation or nitrotyrosine formation as markers for ONOOmediated reaction) approaches. To explore directly the role(s) of peroxynitrite in disease, we have used a class of porphyrin-containing compounds that catalytically decompose peroxynitrite to nitrate (39) . These catalysts do not react directly with either O 2 or NO (39) and therefore can be used to assess the direct contributions of ONOO (39 -41) . Catalysis is proposed to proceed via an oxo-Fe (IV) intermediate generated from the metal-promoted cleavage of the O-O bond. Subsequent recombination with NO 2 regenerates the Fe(III) state and produces nitrate. These catalysts thus dramatically increase the rate of ONOO isomerization, preempting the formation of oxidizing radical species and generating the harmless nitrate anion. This mode of catalysis manifests itself by dramatic shifts in the resulting nitrite-to-nitrate ratio when compared with the proton-catalyzed decomposition (39 -42) . Two of these catalysts, 5,10,15,20-tetrakis(2,4,6-trimethyl-3,5-disulfonatophenyl)-porphyrinato iron (III) (FeTMPS) and 5,10,15,20-tetrakis(2,4,6-trimethyl-3,5-disulfonatophenyl)-porphyrin iron (III) (FeTMPyP), were found to be effective both in vitro and in vivo at removing ONOO and preventing its cytotoxic effects resulting in potent antiinflammatory effects (40, 41) . More important, pharmacological use of these catalysts allowed us to demonstrate for the first time that peroxynitrite indeed plays a key role in vivo in the development of ischemia and reperfusion. In the present study, we examined the protective effect of FeTMPS against oxidative stress during reperfusion of the splanchnic region after induced ischemia using both biochemical and morphological parameters.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats (250 -300 g; Charles River; Milan; Italy) were housed in a controlled environment and provided with standard rodent chow and water. 
Surgical procedures
Male Sprague-Dawley rats weighing 250 -300 g were allowed access to food and water ad libitum. The rats were anesthetized with sodium pentobarbital (45 mg/kg, intraperitoneal). After anesthesia, catheters were placed in the carotid artery and jugular vein as described previously (43) . Blood pressure was monitored continuously by a Maclab A/D converter (AD Instruments, Ugo Basile, Comerio (Ua), Italy), and stored and displayed on a Macintosh personal computer. After midline laparotomy, the celiac and superior mesenteric arteries were isolated near their aortic origins. During this procedure, the intestinal tract was maintained at 37°C by placing it between gauze pads soaked with warmed 0.9% NaCl solution. Rats were observed for a 30 min stabilization period before either splanchnic ischemia or sham ischemia. SAO shock was induced by clamping both the superior mesenteric artery and the celiac trunk, resulting in a total occlusion of these arteries for 45 min. After this period of occlusion, the clamps were removed. In one study, the various groups of rats were killed at 60 min for histological examination of the bowel and for biochemical studies, as described below.
Experimental groups
In the treated group of animals, ONOO decomposition catalyst was given as an intravenous (i.v.) bolus 10 mg/kg i.v injection 30 min before reperfusion (SAOϩFeTMPS group). In a vehicle-treated group of rats, vehicle (saline) was given instead of ONOO decomposition catalyst (SAO group). In separate groups of rats, surgery was performed identically to the SAO group, except that the blood vessels were not occluded (time-controlled sham group, Sham). In an additional group of animals, SAO shock was combined with the administration of ONOO inactive catalyst compound (dose as above) (SAOϩH 2 TMPS inactive decomposition catalyst).
Measurement of nitrite/nitrate in the plasma
Nitrite/nitrate levels, an indicator of NO synthesis, were measured in plasma samples from sham or SAO-shocked rats at 60 min after reperfusion as described previously (31) . First, nitrate in the plasma was reduced to nitrite by incubation with nitrate reductase (670 mU/ml) and NADPH (160 M) at room temperature for 3 h. After 3 h, nitrite concentration in the samples was measured by the Griess reaction by adding 100 l of Griess reagent (0.1% naphthalethylenediamine dihydrochloride in H 2 O and 1% sulfanilamide in 5% concentrated H 3 PO 4 ; vol. 1: 1) to 100 l samples. The optical density at 550 nm (OD 550 ) was measured using a Spectramax 250 microplate reader (Molecular Devices Sunnyvale, Calif.). Nitrate concentrations were calculated by comparison with OD 550 of standard solutions of sodium nitrate prepared in saline solution.
Measurement of peroxynitrite production
The formation of peroxynitrite was estimated by the peroxynitrite-dependent oxidation of dihydrorhodamine 123 to rhodamine, using a previously described method (31) . In separate groups, animals were injected with dihydrorhodamine 123 (2 mol/kg in 0.3 ml saline i.v.) 40 min after reperfusion. Twenty minutes later, rats were killed and plasma samples were taken for rhodamine fluorescence evaluation using a Perkin-Elmer fluorometer (Model LS50B; Perkin-Elmer, Norwalk, Conn.) at an excitation wavelength of 500 nm, emission wavelength of 536 nm (slit widths 2.5 and 3.0 nm, respectively). The rate of rhodamine formation, an index of peroxynitrite production, was calculated using a standard curve obtained with authentic rhodamine (1-30 nM) prepared in plasma obtained from untreated rats. Background plasma fluorescence was subtracted from all samples.
Immunohistochemical localization of nitrotyrosine
Tyrosine nitration, an index of the nitrosylation of proteins by peroxynitrite and/or oxygen-derived free radicals, was determined by immunohistochemistry as described previously (31) . After reperfusion, tissues were fixed in 10% buffered formalin and 8 m sections were prepared from paraffinembedded tissues. After deparaffinization, endogenous peroxidase was quenched with 0.3% H 2 O 2 in 60% methanol for 30 min. The sections were permeabilized with 0.1% Triton X-100 in phosphate-buffered saline (PBS) for 20 min. Nonspecific adsorption was minimized by incubating the section in 2% normal goat serum in PBS for 20 min. Endogenous biotin or avidin binding sites were blocked by sequential incubation for 15 min with avidin and biotin (DBA, Milan, Italy). The sections were then incubated overnight with 1:1000 dilution of primary anti-nitrotyrosine antibody (DBA) or with control solutions. Controls included buffer alone or nonspecific purified rabbit immunoglobulin G (IgG). Specific labeling was detected with a biotin-conjugated goat anti-rabbit IgG and avidin-biotin peroxidase complex (DBA).
Immunohistochemical analysis of P-selectin and ICAM-1
P-selectin and ICAM-1 localization was detected as described previously (44) in ileum sections by immunohistochemistry. After reperfusion, tissues were fixed in 10% buffered formalin; sections were permeabilized with 0.1% Triton X-100 in PBS for 20 min and incubated in 2% normal rat serum (for P-selectin evaluation) or hamster serum (for ICAM-1) for 2 h in order to minimize nonspecific adsorption. Sections were then incubated overnight 4°C with monoclonal biotinylated antibodies directed at P-selectin (rat anti-mouse CD62P) or ICAM-1 (hamster anti-mouse CD54) at dilution 1:500. Controls included buffer alone or nonspecific purified IgG. Antibody binding sites were visualized by an avidin-biotin peroxidase complex immunoperoxidase technique (Vector Laboratories, Burlingame, Calif.) using diaminobenzidine.
Immunocytochemistry photographs (nϭ5) were assessed by densitometry. The assay was carried out by using Optilab Graftek software on a Macintosh personal computer (CPU G3-266).
Myeloperoxidase (MPO) activity
MPO activity, an index of PMN accumulation, was determined as described previously (10) . Intestinal tissues, collected 60 min after reperfusion, were homogenized in a solution containing 0.5% hexa-decyl-trimethyl-ammonium bromide dissolved in 10 mM potassium phosphate buffer (pH 7) and centrifuged for 30 min at 20,000 g at 4°C. An aliquot of the supernatant was then allowed to react with a solution of tetra-methyl-benzidine (1.6 mM) and 0.1 mM H 2 O 2 . The rate of change in absorbance was measured by a spectrophotometer at 650 nm. MPO activity was defined as the quantity of enzyme degrading 1 mol of peroxide min Ϫ1 at 37°C and was expressed in units per gram weight of wet tissue.
Leukocyte count
Tail vein blood samples for leukocyte count were taken at 60 min after reperfusion. The number of leukocytes (WBCϫ10 3 /mm 3 ) is shown as mean Ϯ sd.
Malonaldehyde (MDA) measurement
Levels of MDA in the intestinal tissues were determined as an index of lipid peroxidation, as described by Okhawa et al. (45) . Intestinal tissues, collected 60 min after reperfusion, were homogenized in 1.15% KCl solution. An aliquot (100 l) of the homogenate was added to a reaction mixture containing 200 l of 8.1% sodium dodecyl sulfate, 1500 l of 20% acetic acid (pH 3.5), 1500 l of 0.8% thiobarbituric acid, and 700 l distilled water. Samples were then boiled for 1 h at 95°C and centrifuged at 3000 g for 10 min. The absorbance of the supernatant was measured by spectrophotometry at 650 nm.
Measurement of cytokines
Tumor necrosis factor ␣ (TNF-␣) and interleukin 1␤ (IL-1␤) levels were evaluated in plasma samples at 60 min after reperfusion. The assay was carried out by using a colorimetric commercial kit (Calbiochem-Novabiochem Corporation, San Diego, Calif.). The enzyme-linked immunoassay has a lower detection of 30 pg/ml.
Light microscopy
For histopathological examination, biopsies of small intestine were taken 60 min after reperfusion. The tissue were fixed in Dietric solution (14.25% ethanol, 1.85% formaldehyde, 1% acetic acid) for 1 wk at room temperature, dehydrated by graded ethanol, and embedded in Paraplast (Sherwood Medical, Mahwah, N.J.). From each biopsy, 7 m thick sections were obtained, then stained with trichromic Van Gieson and studied using light microscopy (Dialux 22 Leitz).
Evaluation of survival
The various groups of rats were monitored for 4 h after SAO and reperfusion, and survival rates and survival times were evaluated.
Reagents
Biotin blocking kit, biotin-conjugated goat anti-rabbit IgG, and avidin-biotin peroxidase complex were obtained from Vector Laboratories. Primary anti-nitrotyrosine antibody was purchased from Upstate Biotech (Saranac Lake, N.Y.). Dihydrorhodamine 123 and rhodamine 123 were purchased from Molecular Probes (Eugene Oreg.). Peroxynitrite decomposition catalysts were prepared as described previously (39) .
Data analysis
All values in the figures and text are expressed as mean Ϯ standard error of the mean of n observations, where n represents the number of animals studied. In experiments involving histology or immunohistochemistry, the figures shown are representative of at least three experiments performed on different experimental days. Data sets were examined by one-and two-way analysis of variance and individual group means were then compared with Student's unpaired t test. Nonparametric data were analyzed with the Fisher's exact test. A P value of less than 0.05 was considered significant.
RESULTS
Protective effects of peroxynitrite decomposition catalysts in splanchnic artery occlusion shock
Occlusion of the splanchnic arteries produced an increase in MAP, which then decreased until death (Fig. 1) . The mean survival time was found to be 90 Ϯ 5 min (nϭ27) whereas control sham animals survived for the entire period of observation (4 h, nϭ24; Table 1 ). Having established the survival time, in another series of experiments animals were killed either after the period of ischemia or 60 min post reperfusion in order to collect blood and tissues for biochemical analysis. Reperfusion of the ischemic splanchnic circulation led to a substantial increase in plasma lipid peroxidation products, as determined by increased levels of MDA (Fig. 2) , TNF-␣, and IL1␤ (Fig. 3) , and a profound infiltration of neutrophils into the intestine (the degree of infiltration was much more significant in the lungs than in the ileum by at least 10-to 15-fold) (Fig. 4) . These inflammatory events were triggered by the reperfusion phase since no changes were observed when blood or tissues were removed after the period of ischemia alone (not shown).
When given i.v 30 min prior to reperfusion, the active peroxynitrite decomposition catalyst FeTMPS (1-10 mg/kg, nϭ6) , but not the inactive catalyst H 2 TMPS (10 mg/kg, nϭ6), inhibited in a dosedependent manner the increased plasma and ileum levels of MDA ( Fig. 2A, B) as well as TNF-␣ and IL-1␤ (Fig. 3) . FeTMPS significantly reduced the neutrophils infiltration into the ileum (Fig. 4) .
Therefore, FeTMPS (nϭ6) but not H 2 TMPS (nϭ6), both at 10 mg/kg, prevented the fall in blood pressure (Fig. 1) seen after reperfusion and increased the survival time (90Ϯ5% survival at 4 h in FeTMPS-treated rats vs. 0% survival at 4 h in untreated rats; Table 1 ).
NO and peroxynitrite production in splanchnic artery occlusion shock
There was no change in the plasma levels of nitrate/ nitrite at 60 min of the reperfusion period (Fig. 5A) , in agreement with previous observations where we have demonstrated that the current protocol of ischemia and reperfusion does not trigger the expression of the inducible isoform of NOS (31, 46). Treatment with FeTMPS or H 2 TMPS did not affect baseline nitrite/nitrate levels (Fig. 5A) .
In agreement with previous observations (31, 46), SAO shock caused a significant increase in the rhodamine fluorescence of plasma, indicative of peroxynitrite-induced oxidation of dihydrorhodamine during the reperfusion phase (Fig. 5B) . In vivo treatment with FeTMPS reduced the oxidation of dihydrorhodamine 123 during reperfusion (Fig. 5B) .
At 60 min after reperfusion, ileum sections were taken from sham or shocked rats in order to determine the immunohistological staining for nitrotyrosine. Although there was negligible staining in the intestinal sections of control animals (Fig. 6A) , immunohistochemical analysis, using a specific antinitrotyrosine antibody, revealed a positive staining (14.23Ϯ1.2% of total tissue area) in ileum from SAO-shocked rats (see arrows; Fig. 6B ). In agreement with its effect on plasma dihydrorhodamine oxidation (Fig. 5B) , FeTMPS reduced the degree of immunostaining for nitrotyrosine (1.2Ϯ0.9% and 1.4Ϯ0.6 respectively of total tissue area) in the reperfused intestine (Fig. 6C) .
The inactive catalyst H 2 TMPS did not affect dihydrorhodamine oxidation (Fig. 6B ) or nitrotyrosine formation (data not shown).
Leukocyte count
The administration of FeTMPS did not modify the leukocyte count in sham-shocked rats. In contrast, SAO shock produced a marked leukopenia. Our data show that the leukocyte count was markedly decreased at 60 min after reperfusion. The administration of FeTMPS significantly ameliorated leukopenia ( Table 2) . In contrast, H 2 TMPS did not affect leukopenia (Table 2) .
Immunohistochemical localization of P-selectin and ICAM-1 in the reperfused intestine
Ileum tissue section obtained from SAO-shocked rats undergoing 45 min of ischemia, followed by 1 h reperfusion, showed positive staining (3.026Ϯ0.04% of total tissue area) for P-selectin localized in the vascular endothelial cells of microvessels (see arrows Fig. 7B) . No staining was observed in sham-operated rats (Fig. 7A) . In tissue obtained from FeTMPStreated rats, no up-regulation of P-selectin was found during ischemia and reperfusion (Fig. 7C) . Staining of ileum tissue sections obtained from sham-operated rats with anti-ICAM-1 antibody showed a specific staining along vessels, demonstrating that ICAM-1 is constitutively expressed (1.117Ϯ0.035% of total tissue area) in endothelial cells (see arrows ; Fig. 8A) . After 1 h of reperfusion, the staining intensity increased substantially along vessels and in the necrotic tissues (6.07Ϯ0.052% of total tissue area) (Fig.   8B, arrows) . Sections from FeTMPS-treated rats did not reveal any up-regulation of the constitutive ICAM-1 (Fig. 8C, arrow) , which normally was expressed in the endothelium along the vascular wall (2.11Ϯ0.09%; of total tissue area). H 2 TMPS (inactive catalyst) did not affect adhesion molecule expression (data not shown).
Histological change
Histological examinations of the small intestine at 60 min of reperfusion (see Fig. 9 ) revealed pathological changes. Ileum section showed inflammatory infiltration (see arrows) by neutrophil and lymphocytes extending through the wall and concentrated below the epithelial layer (Fig. 9B) . FeTMPS-treated rats show a significant reduction in organ injury (Fig.  9C) . H 2 TMPS (inactive catalyst) did not affect ileum injury (data not shown).
DISCUSSION
A greater understanding of the role played by peroxynitrite in the pathogenesis of human disease will aid in the design of rational therapies for pharmacological intervention. Peroxynitrite is thought to posses a dual free radical nature capable of hydroxyl radical-like lipid peroxidation and NO 2 -driven nitration of tyrosine. Stability of ONOO is pH dependent, with protonation resulting in either decomposition into predominantly nitrate or the initiation of oxidative processes, including lipid peroxidation and the nitration of tyrosine. ONOO is a powerful oxidant that is highly reactive toward biological molecules, including protein and nonprotein sulfhydryls, DNA, and membrane phospholipids (34) . Peroxynitrite is also stable enough to cross several cell diameters to reach target cells before becoming protonated and decomposing (48) . It is therefore not surprising that evidence is increasing for a major role for peroxynitrite in the development of tissue damage during inflammation (49, 50) as well as in human subjects during sepsis (51) . Nevertheless, as indicated earlier, implications for the participation of peroxynitrite in disease have relied on indirect evidence, mainly through the measurement of nitrotyrosine. The presence of nitrotyrosine at the site of injury does not prove, however, that peroxynitrite caused the damage, but simply that it is formed. Nitrotyrosine formation, along with its detection by immunostaining, was initially proposed as a relatively specific means for detection of the footprint of peroxynitrite (52) . Recent evidence indicates, however, that certain other reactions can also induce tyrosine nitration: the reaction of nitrite with hypochlorous acid and the reaction of MPO with hydrogen peroxide can lead to the formation of nitrotyrosine (53) . Increased nitrotyrosine staining is thus considered an indication of increased nitrosative stress rather than a specific marker of peroxynitrite. Our results using pharmacological agents specific for peroxynitrite decomposition (40 -42) clearly indicate that peroxynitrite is the major cause of the intestinal damage after ischemia and reperfusion. FeTMPS and FeTMPyP, which have been shown to be active peroxynitrite decomposition catalysts (39 -41) , protected against microvascular injury, lipid peroxidation, and epithelial cell injury. In addition, we have recently evidenced the efficacy of ONOO decomposition catalysts in vitro and in vivo (40 -42) . At the cellular level, the catalyst FeTMPS was cytoprotective against exogenously added ONOO with an EC 50 of Ϸ 3.5 M, a concentration almost 1/60th of the ONOO added. This protection correlated well with a reduction in the nitrotyrosine content of cellular proteins released after ONOO insult, an observation consistent with the proposed mechanism of action for these compounds. Moreover, we report that neither TMPS, an inactive structurally related compound, nor free Fe was cytoprotective (40 -42) .
Our data demonstrate that FeTMPS treatment exerts an important protective effect against SAO shock. In fact, the present study provides evidence that 1) FeTMPS reduced the development of SAOinduced shock, 2) FeTMPS reduced morphological injury in SAO shock, 3) FeTMPS reduced lipid peroxidation, 4) in FeTMPS-treated rats subjected to occlusion and reperfusion of the splanchnic artery, up-regulation of P-selectin and ICAM-1 in the ileum was completely abolished, 5) FeTMPS reduced neutrophil infiltration, and 6) FeTMPS reduced cytokine production.
Endothelial cells appear to be major regulators of neutrophil traffic, regulating the process of neutrophil chemoattraction, adhesion, and emigration from the vasculature to the tissue. During the early phase of reperfusion, P-selectin is rapidly released to the cell surface from preformed storage pools after exposure to certain stimuli, such as hydrogen peroxide, thrombin, histamine, or complement, and allows the leukocytes to roll along the endothelium (16, 20) . ICAM-1 constitutively expressed on the surface of endothelial cells is then involved in neutrophil adhesion (16, 54) . Hypoxic endothelial cells synthesize proinflammatory cytokines, which can up-regulate endothelial expression of the constitutive adhesion molecule ICAM-1 in autocrine fashion (55) . Significant expression of ICAM-1 in microvessels of previously ischemic tissues occurs within 1 h after reperfusion (56) . The expression of P-selectin and ICAM-1 corresponds with the induction of neutrophil recruitment, which is maximal within the first hour of reperfusion and persists at a lower rate in the late phase of reperfusion (43, 57) . In accordance with these findings, we observed that a 45 min occlusion of the splanchnic artery, followed by 1 h reperfusion, induced the synthesis of proinflammatory cytokines (TNF-␣ and IL-1␤) and the appearance of P-selectin on the endothelial vascular wall, and up-regulated the surface expression of ICAM-1 on endothelial cells. FeTMPS treatment reduced proinflammatory cytokines production ( Fig. 3) and abolished the expression of P-selectin and the up-regulation of ICAM-1 (Fig. 4C, Fig. 5C ) while not affecting the constitutive levels of ICAM-1 on endothelial cells (data not shown). Numerous cell types release superoxide anions during the inflammatory response and these include endothelial cells, epithelial cells, macrophages, and neutrophils (58, 59) . As seen here, neutrophils do infiltrate into the intestine and their activation at the site of injury may contribute to O 2 -production and subsequent damage. Recent evidence supports a damaging role of superoxide in the gastrointestinal tract (60) . Neutrophils are probably the main source for the release of superoxide and presumably play a major role in the generation of peroxynitrite.
Evidence that reactive nitrogen and oxygen species can exert proinflammatory properties includes recruitment of neutrophils at sites of inflammation, formation of chemotactic factors (58, 59) , DNA damage, depolymerization of hyaluronic acid and collagen (61, 62) , lipid peroxidation, and release of cytokines such as TNF-␣ and IL-1␤.
We can hypotheses that the mechanism of this peroxynitrite decomposition catalyst may be related to a prevention of peroxynitrite-induced endothelial injury as well as to the inhibition of reactive nitrogen and oxygen intermediates proinflammatory properties. In other words, we propose a positive feedback cycle in SAO shock (Fig. 10) . Peroxynitrite decomposition catalyst would intercept this cycle at the level of endothelial injury and cytokine release. This model would explain the reduction of cytokine formation and the reduction of P-selectin and ICAM-1 and PMNs infiltration during reperfusion in the FeTMPS-treated rats.
In conclusion, we have directly demonstrated that peroxynitrite is associated with the intestinal damage evoked by ischemia and reperfusion. The peroxynitrite decomposition catalysts may offer a novel approach for manipulating the pathological sequelae that are associated with ischemia and reperfusion. The further use of these catalysts as pharmacological tools in animals models of human disease may lead to a better understanding of when and where peroxynitrite plays a key role(s) in the development of inflammatory diseases such as ischemia and reperfusion. This, in turn, should provide more effective treatment strategies in the clinic for disease. Peroxynitrite decomposition catalysts are not only useful tools for the pharmacological dissection of free radical-mediated pathology, but also offer promise as disease-modifying therapeutic agents capable of preserving the positive aspect of the double-edged sword of nitric oxide action. 
